No Data
No Data
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Barclays Maintains Molina Healthcare(MOH.US) With Hold Rating, Cuts Target Price to $359
Stephens Adjusts Price Target on Molina Healthcare to $320 From $355
Does Molina Healthcare (NYSE:MOH) Deserve A Spot On Your Watchlist?
Barclays Adjusts Price Target on Molina Healthcare to $359 From $430, Maintains Equalweight Rating
Molina Healthcare of Texas Medical Director of Maternal and Women's Health Appointed to Texas Maternal Mortality and Morbidity Committee